Evidence map›Paper›PMID 37747363›Full record

ArticleOncotarget2023

Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide.

Alessandro Canella, Hector Cordero Nieves, Douglas W Sborov, Luciano Cascione, Hanna S Radomska, Emily Smith, Andrew Stiff, Jessica Consiglio, Enrico Caserta, Lara Rizzotto and 8 more

Open access · diamondAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Alessandro Canella *Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Hector Cordero Nieves *Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Douglas W SborovDepartment of Internal Medicine, Oncology/Hematology Fellowship, The Ohio State University, Columbus, OH, USA.
Luciano CascioneLymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland.
Hanna S RadomskaDepartment of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Emily SmithDepartment of Internal Medicine, Biomedical Sciences Graduate Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Andrew StiffDepartment of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Jessica ConsiglioDepartment of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Enrico CasertaDepartment of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Lara RizzottoDepartment of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Nicola ZanesiDepartment of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Volinia StefanoDepartment of Internal Medicine, Biosystems Analysis, LTTA, Department of Morphology, Surgery and Experimental Medicine, Università degli Studi, Ferrara, Italy.
Balveen KaurDepartment of Neurological Surgery, Dardinger Laboratory for Neuro-oncology and Neurosciences, The Ohio State University Medical Center, Columbus, Ohio, USA.
Xiaokui MoDepartment of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
John C ByrdDepartment of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Yvonne A EfeberaDepartment of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.
Craig C HofmeisterDepartment of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.
Flavia PichiorriDepartment of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
The Ohio State University · USZero to Three · USDiscovery Institute · USInstitute of Oncology Research · CHThe Ohio State University Wexner Medical Center · USUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37747363
PMCPMC10519243
OpenAlexW4387002318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.